𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiviral therapy in advanced chronic liver disease due to hepatitis C virus infection: Pilot study

✍ Scribed by RAKESH KUMAR; SUDHEER KUMAR; BARJESH CHANDER SHARMA; JAGDEEP SINGH; SHIV K SARIN


Book ID
108950223
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
97 KB
Volume
20
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Susceptibility to hepatitis A in patient
✍ Michael Shim; Inessa Khaykis; James Park; Edmund J. Bini 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

Hepatitis A virus (HAV) superinfection is associated with a high risk of liver failure and death in patients with underlying chronic liver disease. Although HAV vaccination is recommended for all patients with chronic hepatitis C virus (HCV) infection, little is known about adherence to these recomm

Antiviral treatment of chronic hepatitis
✍ George H. Scullard; Ljudevit L. Andres; Harry B. Greenberg; Joseph L. Smith; Vin 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 1 views

Twelve of 32 patients lost HBeAg and DNA polymerase from their serum after completing antiviral therapy with interferon and/or adenine arabinoside. Three lost serum HBsAg as well. Loss of corresponding viral markers from hepatic tissue was also seen. There was improvement in symptoms, hepatic tests,

Clinical progression of hepatitis C viru
✍ Juan A. Pineda; José A. García-García; Manuela Aguilar-Guisado; María J. Ríos-Vi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 2 views

Little is known about the natural history of liver disease in human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected subjects under highly active antiretroviral therapy (HAART). The objectives of this study were to obtain information about the mortality, the incidence of hepatic decom